These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
640 related articles for article (PubMed ID: 18305202)
1. Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections. Meers P; Neville M; Malinin V; Scotto AW; Sardaryan G; Kurumunda R; Mackinson C; James G; Fisher S; Perkins WR J Antimicrob Chemother; 2008 Apr; 61(4):859-68. PubMed ID: 18305202 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa. Tré-Hardy M; Traore H; El Manssouri N; Vanderbist F; Vaneechoutte M; Devleeschouwer MJ Int J Antimicrob Agents; 2009 Oct; 34(4):370-4. PubMed ID: 19505804 [TBL] [Abstract][Full Text] [Related]
3. Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin. Ehsan Z; Clancy JP Future Microbiol; 2015; 10(12):1901-12. PubMed ID: 26573178 [TBL] [Abstract][Full Text] [Related]
4. Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa. Alipour M; Suntres ZE; Omri A J Antimicrob Chemother; 2009 Aug; 64(2):317-25. PubMed ID: 19465435 [TBL] [Abstract][Full Text] [Related]
5. Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa. Halwani M; Yebio B; Suntres ZE; Alipour M; Azghani AO; Omri A J Antimicrob Chemother; 2008 Dec; 62(6):1291-7. PubMed ID: 18931388 [TBL] [Abstract][Full Text] [Related]
6. Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa. Halwani M; Hebert S; Suntres ZE; Lafrenie RM; Azghani AO; Omri A Int J Pharm; 2009 May; 373(1-2):141-6. PubMed ID: 19429299 [TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosa in vitro and biofilm infections in a rat model. Cai Y; Fan Y; Wang R; An MM; Liang BB J Antimicrob Chemother; 2009 Sep; 64(3):563-6. PubMed ID: 19561148 [TBL] [Abstract][Full Text] [Related]
8. Attenuation of Pseudomonas aeruginosa virulence factors and biofilms by co-encapsulation of bismuth-ethanedithiol with tobramycin in liposomes. Alipour M; Suntres ZE; Lafrenie RM; Omri A J Antimicrob Chemother; 2010 Apr; 65(4):684-93. PubMed ID: 20159770 [TBL] [Abstract][Full Text] [Related]
9. Chelated iron sources are inhibitors of Pseudomonas aeruginosa biofilms and distribute efficiently in an in vitro model of drug delivery to the human lung. Musk DJ; Hergenrother PJ J Appl Microbiol; 2008 Aug; 105(2):380-8. PubMed ID: 18284482 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of Aerosolized Rifaximin versus Tobramycin for Treatment of Pseudomonas aeruginosa Pneumonia in Mice. Kirby BD; Al Ahmar R; Withers TR; Valentine ME; Valentovic M; Long TE; Gaskins JR; Yu HD Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010865 [No Abstract] [Full Text] [Related]
11. Effects of intratracheal administration of novispirin G10 on a rat model of mucoid Pseudomonas aeruginosa lung infection. Song Z; Wu H; Mygind P; Raventos D; Sonksen C; Kristensen HH; Høiby N Antimicrob Agents Chemother; 2005 Sep; 49(9):3868-74. PubMed ID: 16127064 [TBL] [Abstract][Full Text] [Related]
13. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae. Lee MY; Ko KS; Song JH; Peck KR J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978 [TBL] [Abstract][Full Text] [Related]
14. Bioavailability of a small unilamellar low-clearance liposomal amikacin formulation after extravascular administration. Fielding RM; Moon-McDermott L; Lewis RO J Drug Target; 1999; 6(6):415-26. PubMed ID: 10937287 [TBL] [Abstract][Full Text] [Related]
15. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa. Herrmann G; Yang L; Wu H; Song Z; Wang H; Høiby N; Ulrich M; Molin S; Riethmüller J; Döring G J Infect Dis; 2010 Nov; 202(10):1585-92. PubMed ID: 20942647 [TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571 [TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time-kill study. Rukholm G; Mugabe C; Azghani AO; Omri A Int J Antimicrob Agents; 2006 Mar; 27(3):247-52. PubMed ID: 16472992 [TBL] [Abstract][Full Text] [Related]
18. Incorporation of Farnesol Significantly Increases the Efficacy of Liposomal Ciprofloxacin against Pseudomonas aeruginosa Biofilms in Vitro. Bandara HM; Herpin MJ; Kolacny D; Harb A; Romanovicz D; Smyth HD Mol Pharm; 2016 Aug; 13(8):2760-70. PubMed ID: 27383205 [TBL] [Abstract][Full Text] [Related]
19. Novel amikacin inhaled formulation for the treatment of lower respiratory tract infections. Antoniu S; Azoicai D Drugs Today (Barc); 2013 Nov; 49(11):683-92. PubMed ID: 24308015 [TBL] [Abstract][Full Text] [Related]
20. Antibacterial efficacy of inhaled squalamine in a rat model of chronic Pseudomonas aeruginosa pneumonia. Hraiech S; Brégeon F; Brunel JM; Rolain JM; Lepidi H; Andrieu V; Raoult D; Papazian L; Roch A J Antimicrob Chemother; 2012 Oct; 67(10):2452-8. PubMed ID: 22744759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]